“Miraculous” HIV drug to be rolled out after overcoming aid cuts threat
|
Lenacapavir is a long acting, injectable,5 pre-exposure
prophylaxis (PrEP) drug that prevents HIV infection. The drug is an HIV-1
capsid inhibitor, ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.